Dimerix Limited has released a press release.
Dimerix Presents at Bioshares Summit 2026
Earlier from Dimerix
- US Patent Granted for Dimerix New Asset DMX-652
- Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
- Dimerix expands pipeline with acquisition of phase 2 ready asset for acute kidney injury